Huntington National Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14 | Hold |
1
| – | – | ﹤0.01% | 3653 |
|
|
2025
Q4 | $14 | Hold |
1
| – | – | ﹤0.01% | 3562 |
|
|
2025
Q3 | $14 | Hold |
1
| – | – | ﹤0.01% | 3596 |
|
|
2025
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 3606 |
|
|
2025
Q1 | $14 | Hold |
1
| – | – | ﹤0.01% | 3627 |
|
|
2024
Q4 | $14 | Hold |
1
| – | – | ﹤0.01% | 3634 |
|
|
2024
Q3 | $14 | Hold |
1
| – | – | ﹤0.01% | 3626 |
|
|
2024
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 3578 |
|
|
2024
Q1 | $14 | Hold |
1
| – | – | ﹤0.01% | 3443 |
|
|
2023
Q4 | $14 | Hold |
1
| – | – | ﹤0.01% | 3343 |
|
|
2023
Q3 | $14 | Hold |
1
| – | – | ﹤0.01% | 3315 |
|
|
2023
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 3289 |
|
|
2023
Q1 | $14 | Hold |
1
| – | – | ﹤0.01% | 3138 |
|
|
2022
Q4 | $14 | Hold |
1
| – | – | ﹤0.01% | 3007 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2582 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2588 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2514 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2443 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2171 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2058 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1949 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1923 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1865 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1874 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1971 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1980 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1887 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$11 | ﹤0.01% | 1917 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 1915 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1972 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | +$23 | ﹤0.01% | 1971 |
|
|
2016
Q2 | – | Sell |
-119
| Closed | -$7K | – | 1735 |
|
|
2016
Q1 | $7K | Buy |
+119
| New | +$2.82K | ﹤0.01% | 1527 |
|
|
2015
Q4 | – | Sell |
-115
| Closed | -$5K | – | 1729 |
|
|
2015
Q3 | $5K | Buy |
115
+16
| +16% | +$993 | ﹤0.01% | 1534 |
|
|
2015
Q2 | $7K | Sell |
99
-20
| -17% | -$1.26K | ﹤0.01% | 1549 |
|
|
2015
Q1 | $7K | Buy |
+119
| New | +$5.67K | ﹤0.01% | 1538 |
|
|
2014
Q1 | – | Sell |
-120
| Closed | -$3K | – | 1638 |
|
|
2013
Q4 | $3K | Hold |
120
| – | – | ﹤0.01% | 1617 |
|
|
2013
Q3 | $3K | Hold |
120
| – | – | ﹤0.01% | 1640 |
|
|
2013
Q2 | $3K | Buy |
+120
| New | +$2.64K | ﹤0.01% | 1626 |
|
Huntington National Bank's AMAG Position: Q1 2026 in Review
Huntington National Bank held its AMAG Pharmaceuticals (AMAG) position steady in Q1 2026 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3653.
Huntington National Bank first reported a position in AMAG in Q2 2013 and has held it in 37 quarters since. The position peaked at $7K in Q1 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q1 2026.
- Huntington National Bank held 1 share of AMAG Pharmaceuticals worth $14 as of Q1 2026.
- Huntington National Bank left its AMAG Pharmaceuticals share count unchanged in Q1 2026.
- AMAG Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3653 holding.
- Huntington National Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
- Huntington National Bank's AMAG Pharmaceuticals position peaked at $7K in Q1 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.